Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Attmann

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 27, 2017
Restrictive enlargement of the pulmonary annulus at repair of tetralogy of Fallot: a comparative 10-year follow-up studyJana Logoteta, Lars Dullin, Jan Hinnerk Hansen, et al.
Clinical Epigenetics|June 13, 2019
DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMsKirstin Hoff, Marta Lemme, Anne-Karin Kahlert, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 24, 2025
Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trialMelanie Arnreiter, Moritz von Scheidt, Johannes M Albes, et al.
American Heart Journal|September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trialAntoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 27, 2017
Restrictive enlargement of the pulmonary annulus at repair of tetralogy of Fallot: a comparative 10-year follow-up studyJana Logoteta, Lars Dullin, Jan Hinnerk Hansen, et al.
Clinical Epigenetics|June 13, 2019
DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMsKirstin Hoff, Marta Lemme, Anne-Karin Kahlert, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 24, 2025
Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trialMelanie Arnreiter, Moritz von Scheidt, Johannes M Albes, et al.
American Heart Journal|September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trialAntoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
Pageof 6